Clinical trials recruiting in Kenya

Phase breakdown

Cities in Kenya

Conditions recruiting in Kenya

Recruiting trials in Kenya

• A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
  NCT07044297 · Phase: Phase 3 · Ages: 16 Years and older · Sex: All (male and female)
• A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
  NCT05431088 · Phase: Phase 2, Phase 3 · Ages: 12 Years and older · Sex: All (male and female)
• A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
  NCT06609226 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female)
• A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
  NCT07071623 · Phase: Phase 3 · Ages: 16 Years to 30 Years · Sex: Female
• A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
  NCT06065748 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
  NCT06612268 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
  NCT05894239 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease
  NCT06198712 · Phase: Phase 2 · Ages: 6 Months to 18 Years · Sex: All (male and female)
• A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
  NCT06439082 · Phase: Phase 3 · Ages: 12 Years to 100 Years · Sex: All (male and female)
• A Trial Testing a Two-way SMS Platform to Recognize and Prevent Wasting Among HIV-infected and HIV-exposed Uninfected Children in Kenya
  NCT06842732 · Phase: Not applicable (e.g. observational or device study) · Ages: 6 Months to 24 Months · Sex: All (male and female)
• Assessing the Effects of a Multisectoral Agricultural Intervention on the Reproductive and Sexual Health of Adolescent Girls and Young Women
  NCT06953310 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years and older · Sex: All (male and female)
• Bridging the Treatment Gap by Expanding Access to Care for People With Epilepsy in Kenya (BEACON)
  NCT06623994 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years and older · Sex: All (male and female)
• Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)
  NCT07170748 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIV
  NCT06999928 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female
• HIV Testing Counselor-led Care to Catalyze Integration of PrEP Delivery in Family Planning Clinics
  NCT07089966 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years and older · Sex: All (male and female)
• Hybrid Type-1 Effectiveness-Implementation Trial of Motivation Matters!
  NCT06745050 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female
• IBIS Megastudy of Interventions to Encourage HIV Retesting
  NCT06971367 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years and older · Sex: All (male and female)
• Improving Perinatal Outcomes Among Kenyan Pregnant Women With an Integrated STI Testing Model
  NCT06203951 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: Female
• Integrated Mental Health Care for Pregnant Women With HIV in Kenya: The Tunawiri Study
  NCT06117163 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years and older · Sex: Female
• Integration of Stepped Care for Perinatal Mood and Anxiety Disorders Among Women Attending MCH Clinics
  NCT06456307 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years and older · Sex: Female
• International Registry for Men With Advanced Prostate Cancer (IRONMAN)
  NCT03151629 · Phase: Not specified · Ages: 21 Years and older · Sex: Male
• Investigating the Optimal Management of Dolutegravir Resistance
  NCT06762054 · Phase: Not specified · Ages: 1 Year and older · Sex: All (male and female)
• Kulindana: Community-friendly Delivery and Monitoring of TPT to Improve Uptake and Reduce TB Transmission
  NCT07628140 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female)
• Kuwa Free! - Live Free!
  NCT05044962 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years to 24 Years · Sex: Female
• Measuring Adverse Pregnancy and Newborn Congenital Outcomes
  NCT04405700 · Phase: Not specified · Ages: No age limits stated · Sex: Female
• Multi-product PrEP Delivery to Young Women Seeking Reproductive Health Services and Coverage of HIV Prevention
  NCT07076043 · Phase: Phase 4 · Ages: 18 Years to 30 Years · Sex: Female
• Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance
  NCT06747507 · Phase: Phase 3 · Ages: 3 Years and older · Sex: All (male and female)
• One-stop PrEP Care Pathway to Simplify PrEP Delivery in Kenya: The One-Stop PrEP Care Project
  NCT05905640 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years and older · Sex: All (male and female)
• Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
  NCT05592938 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 99 Years · Sex: Female
• Peers and Technology for Adherence, Access, Accountability, and Analytics (PT4A)
  NCT06485700 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• PrEP My Way: A Hybrid Type 1 Clinical Effectiveness-implementation Trial to Promote PrEP Persistence Among Young Kenyan Women
  NCT06566430 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years to 24 Years · Sex: Female
• Precision Imaging to Evaluate Kaposi Sarcoma
  NCT06898203 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Protocol RV 583 Multinational Observational Cohort of HIV and Other Infections
  NCT05147519 · Phase: Not specified · Ages: 14 Years to 55 Years · Sex: All (male and female)
• Reaching the Last 20% (the Pamoja Kwa Afya Study)
  NCT05882916 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female
• Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study
  NCT05164263 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Remote Ischaemic Conditioning in STEMI Patients in AFRICA
  NCT04813159 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Scale-up of an Evidence-based Adolescent Transition Package to Support Transitional Care Among Youth Living With HIV
  NCT06924073 · Phase: Not applicable (e.g. observational or device study) · Ages: 10 Years and older · Sex: All (male and female)
• Systems Analysis and Improvement Approach to Improve Integration of HIV Prevention and Treatment Services
  NCT05404958 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female)
• The Alama Project: Autism Outcomes and Neurobehavioral Markers in Young Children Born to Mothers With HIV in Kenya
  NCT06703125 · Phase: Not applicable (e.g. observational or device study) · Ages: 24 Months to 72 Months · Sex: All (male and female)
• The Impact of Vaginal Washing on Cervical Inflammation
  NCT06615232 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 50 Years · Sex: Female
• Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
  NCT02140255 · Phase: Phase 1, Phase 2 · Ages: Up to 48 Hours · Sex: All (male and female)
• iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
  NCT03549754 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Kenya?

42 recruiting trials have at least one study site in Kenya.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.